# A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects

> **NCT06858657** · PHASE1 · COMPLETED · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 82 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HSK44459
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06858657
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-17
- **Primary completion:** 2024-11-18
- **Final completion:** 2024-12-20
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06858657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06858657, "A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06858657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*